Table 1.
Characteristics of patients who received Tenofovir, TTSH, Singapore, Jul. 2007 – Dec. 2009 (N = 226)
| No (%) of patients at TDF Initiation | |
|---|---|
|
Sex | |
| Male |
203 (89.9) |
| Female |
23 (10.1) |
|
Ethnicity | |
| Chinese |
176 (78.6) |
| Malay |
26 (11.6) |
| Indian |
10 (4.5) |
| Others |
12 (5.3) |
|
Age | |
| Median (range) |
46 (23 – 82) |
|
Weight | |
| Median (IQR) |
60.0 [53.75 - 68.0] |
|
ART Regimen | |
| NNRTI-based |
118 (52.2) |
| PI - based |
108 (47.8) |
|
Co-morbidity | |
| Hepatitis B co-infection |
63 (27.9) |
| Diabetes mellitus |
26 (11.5) |
| Hypertension |
23 (10.2) |
| Chronic renal disease |
2 (0.9) |
|
CD4 cell count (cells/mm3) | |
| Median [IQR] |
127 [38–258] |
|
Viral Load (Log10Copies/mL) | |
| Median [IQR] |
4.9 [4.2-5.5] |
|
Creatinine clearance (mL/min) | |
| Median [IQR] |
82.7 [71.4-101.7] |
| >/= 90 |
72 (43.3) |
| 60-89 |
73 (43.9) |
| 30-59 |
20 (12.2) |
| <30 | 1 (0.6) |